152 related articles for article (PubMed ID: 36574147)
1. Looking at the spine in controlled Acromegaly.
Birtolo MF; Antonini S; Lania AG; Mazziotti G
Endocrine; 2023 Feb; 79(2):283-286. PubMed ID: 36574147
[TBL] [Abstract][Full Text] [Related]
2. Vertebral Fractures Associated with Spinal Sagittal Imbalance and Quality of Life in Acromegaly: A Radiographic Study with EOS 2D/3D Technology.
Cellini M; Biamonte E; Mazza M; Trenti N; Ragucci P; Milani D; Ferrante E; Rossini Z; Lavezzi E; Sala E; Mantovani G; Arosio M; Fornari M; Balzarini L; Lania AG; Mazziotti G
Neuroendocrinology; 2021; 111(8):775-785. PubMed ID: 32980840
[TBL] [Abstract][Full Text] [Related]
3. Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
Chiloiro S; Mazziotti G; Giampietro A; Bianchi A; Frara S; Mormando M; Pontecorvi A; Giustina A; De Marinis L
Pituitary; 2018 Jun; 21(3):302-308. PubMed ID: 29397538
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.
Chiloiro S; Mormando M; Bianchi A; Giampietro A; Milardi D; Bima C; Grande G; Formenti AM; Mazziotti G; Pontecorvi A; Giustina A; De Marinis L
Endocrine; 2018 Feb; 59(2):449-453. PubMed ID: 28836162
[TBL] [Abstract][Full Text] [Related]
5. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study.
Mazziotti G; Battista C; Maffezzoni F; Chiloiro S; Ferrante E; Prencipe N; Grasso L; Gatto F; Olivetti R; Arosio M; Barale M; Bianchi A; Cellini M; Chiodini I; De Marinis L; Del Sindaco G; Di Somma C; Ferlin A; Ghigo E; Giampietro A; Grottoli S; Lavezzi E; Mantovani G; Morenghi E; Pivonello R; Porcelli T; Procopio M; Pugliese F; Scillitani A; Lania AG
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32511698
[TBL] [Abstract][Full Text] [Related]
7. GH receptor isoforms and skeletal fragility in acromegaly.
Mormando M; Nasto LA; Bianchi A; Mazziotti G; Giampietro A; Pola E; Pontecorvi A; Giustina A; De Marinis L
Eur J Endocrinol; 2014 Aug; 171(2):237-45. PubMed ID: 24866575
[TBL] [Abstract][Full Text] [Related]
8. Acromegaly and Vertebral Fractures: Facts and Questions.
Giustina A
Trends Endocrinol Metab; 2020 Apr; 31(4):274-275. PubMed ID: 32187523
[TBL] [Abstract][Full Text] [Related]
9. MANAGEMENT OF ENDOCRINE DISEASE: Bone disorders associated with acromegaly: mechanisms and treatment.
Mazziotti G; Lania AGA; Canalis E
Eur J Endocrinol; 2019 Aug; 181(2):R45-R56. PubMed ID: 31100715
[TBL] [Abstract][Full Text] [Related]
10. Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.
Ribeiro de Moura C; Campos Lopes S; Monteiro AM
Pituitary; 2022 Dec; 25(6):780-794. PubMed ID: 35867180
[TBL] [Abstract][Full Text] [Related]
11. Progression of vertebral fractures in long-term controlled acromegaly: a 9-year follow-up study.
Pelsma ICM; Biermasz NR; Pereira AM; van Furth WR; Appelman-Dijkstra NM; Kloppenburg M; Kroon HM; Claessen KMJA
Eur J Endocrinol; 2020 Oct; 183(4):427-437. PubMed ID: 32688336
[TBL] [Abstract][Full Text] [Related]
12. Acromegalic osteopathy.
Mazziotti G; Maffezzoni F; Frara S; Giustina A
Pituitary; 2017 Feb; 20(1):63-69. PubMed ID: 27709412
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly.
Frara S; Melin Uygur M; di Filippo L; Doga M; Losa M; Santoro S; Mortini P; Giustina A
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2843-e2850. PubMed ID: 35349698
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly.
Wassenaar MJ; Biermasz NR; Hamdy NA; Zillikens MC; van Meurs JB; Rivadeneira F; Hofman A; Uitterlinden AG; Stokkel MP; Roelfsema F; Kloppenburg M; Kroon HM; Romijn JA; Pereira AM
Eur J Endocrinol; 2011 Apr; 164(4):475-83. PubMed ID: 21257726
[TBL] [Abstract][Full Text] [Related]
15. Bone histomorphometry in acromegaly patients with fragility vertebral fractures.
Dalle Carbonare L; Micheletti V; Cosaro E; Valenti MT; Mottes M; Francia G; Davì MV
Pituitary; 2018 Feb; 21(1):56-64. PubMed ID: 29214508
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
[TBL] [Abstract][Full Text] [Related]
17. Update on vertebral fractures in pituitary diseases: from research to clinical practice.
Carrone F; Ariano S; Piccini S; Milani D; Mirani M; Balzarini L; Lania AG; Mazziotti G
Hormones (Athens); 2021 Sep; 20(3):423-437. PubMed ID: 33606197
[TBL] [Abstract][Full Text] [Related]
18. Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience.
Chiloiro S; Giampietro A; Infante A; Mattogno PP; Lauretti L; Olivi A; De Marinis L; Pontecorvi A; Doglietto F; Bianchi A
Pituitary; 2024 Jun; 27(3):303-309. PubMed ID: 38713317
[TBL] [Abstract][Full Text] [Related]
19. Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs.
Chiloiro S; Giampietro A; Frara S; Bima C; Donfrancesco F; Fleseriu CM; Pontecorvi A; Giustina A; Fleseriu M; De Marinis L; Bianchi A
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31613969
[TBL] [Abstract][Full Text] [Related]
20. Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study.
Sardella C; Urbani C; Marconcini G; Cappellani D; Manetti L; De Liperi A; Romei C; Morganti R; Marcocci C; Bogazzi F
J Endocrinol Invest; 2024 Feb; 47(2):325-334. PubMed ID: 37668886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
